1. Project Overview & Global Regulatory Compliance Framework
Our full-lifecycle biomanufacturing facility project delivery provides integrated, single-source turnkey execution for biopharmaceutical plant construction and upgrading, fully compliant with FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 quality risk management and data integrity standards. Covering pre-project consultation, engineering design, equipment manufacturing, on-site construction, system integration, CQV qualification and post-handover operational support, our full-chain delivery model supports end-to-end industrialization for monoclonal antibodies, recombinant proteins, viral vectors and vaccines across pilot-scale laboratories and commercial-grade production campuses. Traditional segmented project delivery commonly generates industry pain points including disjointed design-construction logic, multi-vendor interface conflicts, delayed document validation, inconsistent sanitary workmanship and insufficient post-completion compliance support. Through unified full-lifecycle accountability and standardized execution protocols, we deliver schedule-controlled, cost-stabilized and fully audit-ready biomanufacturing facilities for global biotech enterprises, CMO operators and biopharmaceutical industrial developers.
2. Core Delivery Philosophy & Full-Process Competitive Advantages
Guided by process-driven quality-by-design and risk-based full-lifecycle compliance control, our project delivery embeds bioprocess characteristics and regulatory requirements into every execution stage to achieve intrinsic facility compliance and operational determinism. We integrate self-owned ASME BPE-grade equipment manufacturing capabilities, GMP-standard sanitary construction systems and global regulatory verification experience to eliminate technical gaps between design, fabrication and commissioning. All facility zoning, fluid path layout, utility configuration and automation logic are optimized based on critical process parameters (CPPs) and critical quality attributes (CQAs), ensuring stable batch consistency and effective contamination control throughout production cycles. Different from fragmented delivery models with separated responsibilities, our full-lifecycle closed-loop management unifies quality standards, document systems and risk mitigation strategies, significantly reducing revision rates, shortening project lead times and sustaining long-term GMP inspection readiness for biomanufacturing infrastructure.
3. Four Core Full-Lifecycle Delivery Modules & Standard Deliverables
Our complete full-lifecycle biomanufacturing facility project delivery system consists of four mutually collaborative, fully covered execution modules covering the entire project timeline: pre-project regulatory design & planning module, integrated manufacturing & procurement module, GMP construction & system integration module, and commissioning qualification & lifecycle operation module. The pre-project planning module delivers site feasibility evaluation, master plant layout, BIM 3D spatial optimization, P&ID schematic design and full-set URS/DQ compliance documents adapted to global regulatory markets. The manufacturing and procurement module provides customized bioreactor systems, downstream purification skids and ASME BPE sanitary vessels with unified FAT verification, full material traceability and standardized quality certification. The construction and integration module implements classified cleanroom construction, sanitary orbital welding, HVAC/WFI/CIP utility deployment and cross-system linkage debugging under strict GMP workmanship supervision. The qualification and operation module completes SAT testing, full IQ/OQ/PQ validation, electronic batch record configuration and audit dossier sorting, alongside long-term operational optimization support. Standard deliverables include full engineering archives, validation packages, certification documents and as-built technical files.
4. Industrial Application & Sustainable Lifecycle Support
Our full-lifecycle project delivery services are widely applied in global greenfield biomanufacturing campus development, brownfield GMP compliance retrofitting, clinical pilot process platform construction and multi-product flexible CMO facility upgrading. All delivered facilities adopt modular and scalable architecture, reserving flexible expansion and process intensification interfaces to support future capacity iteration and new biotherapeutic pipeline deployment. We provide sustainable full-lifecycle after-delivery support including regulatory standard update consultation, periodic facility compliance assessment, operational GMP training, process deviation troubleshooting and continuous performance optimization. By implementing standardized, compliance-oriented full-lifecycle project execution, we help global biopharmaceutical clients accelerate facility commissioning and product commercialization, reduce long-term operational risks, and build efficient, stable and internationally competitive biomanufacturing systems.
